Roches Evrysdi tablet approved by European Commission as first and only for Spinal Muscular Atrophy (SMA)
Simplified storage and administration of new tablet formulation may provide greater freedom…
Olympic Refuge Foundation unveils plans to step up support for millions of displaced people around the world with new strategy
03 June 2025 - The Olympic Refuge Foundation (ORF) Board met at Olympic House in…
WinnerMining launches new energy power project.
Boston, Massachusetts, June 03, 2025 (GLOBE NEWSWIRE) -- With the changes of…
Sameer Kanodia, Managing Director and CEO, Lumina Datamatics, and Vice Chairman and CEO, TNQTech, honored with ‘India’s Top 50 CEOs, MDs, and Founders’ Recognition by the Great Manager Institute for 2025
MUMBAI, India, June 3, 2025 /PRNewswire/ -- Sameer Kanodia, Managing Director and…
argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference
June 03, 2025 01:00 ET | Source: argenx SE June 3, 2025Amsterdam,…
Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease…
Roches Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancer
46% reduction in the risk of disease progression or death, and 27%…
UnitedHealth Group Announces Earnings Release Date
--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) will release its second quarter 2025 financial…
Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response
Treatment with casdatifan, a HIF-2a inhibitor, plus cabozantinib, a tyrosine kinase inhibitor,…
New data show Roches Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancer
The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than…